Ipilimumab before BRAF inhibitor treatment may be more beneficial than vice versa for the majority of patients with advanced melanoma (Q87374722)
Jump to navigation
Jump to search
scientific article published on 27 February 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ipilimumab before BRAF inhibitor treatment may be more beneficial than vice versa for the majority of patients with advanced melanoma |
scientific article published on 27 February 2014 |
Statements
Ipilimumab before BRAF inhibitor treatment may be more beneficial than vice versa for the majority of patients with advanced melanoma (English)
Paolo A Ascierto